Please provide your email address to receive an email when new articles are posted on . The safety and efficacy of selective laser trabeculoplasty was comparable to argon laser trabeculoplasty. Data ...

Please provide your email address to receive an email when new articles are posted on . Both initial and repeat SLT were associated with IOP reduction, but repeat SLT had longer duration of effect.

CHICAGO -- Upfront laser trabeculoplasty significantly slowed glaucoma progression and vision loss as compared with eye drops, long-term follow-up from a large randomized trial showed. After 6 years ...

Looking back, glaucoma specialists like Dr. Christine Funke of Barnet Dulaney Perkins Eye Center can remember a time not long ago when treatment options for the eye condition were greatly limited.

SLT is emerging as a cost-effective first-line treatment, offering superior intraocular pressure stability compared to traditional eye drops. Minimally invasive glaucoma surgeries, like the iStent ...

GENEVA--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care, dedicated to helping people see brilliantly, announced today the full U.S. commercial availability of Voyager™ DSLT, the ...

Glaucoma is a lifelong eye disease that requires regular treatment. For many, it can be controlled by a daily eye drop regimen, but the treatment is not perfect—the preservatives in the drops can ...

ALISO VIEJO, Calif.--(BUSINESS WIRE)--ViaLase, Inc., a clinical-stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced that the first patient ...

California-based medical technology startup ViaLase has announced that its ViaLase Laser device for glaucoma treatment has received CE mark approval. The approval moves the platform towards ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...